IBRX
ImmunityBio, Inc. · Healthcare · Biotechnology
$10.28
+10.83% today · +21.86% 1W
Oct 2 close or latest
PreviewWhy it's moving
Outperforming without a clear catalyst yet
- IBRX +10.83% on the last session vs SPY +0.74%: +10.1 pts of stock-specific move.
- Aftermath, rsi overbought (Oct 2): After its 11 overbought readings in the past 5 years, IBRX typically lost 5.3% over the next month (median) and was higher only 45% of the time; half the outcomes fell between -16.9% and +32.6%. An ordinary month: -1.8%. Among S&P 500 stocks after overbought readings, that ranks #263 of 501.
- 0 Reddit mentions in the past 24 hours, 81% positive over the week · today's pace is 1.5× its recent daily average.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
IBRX against the S&P 500 components
| Window | Rank of 500 | Position | Gain | SPY gain |
|---|---|---|---|---|
| 1 day | #1 | +10.83% | +0.74% | |
| 1 week | #1 | +21.86% | -0.22% | |
| 1 month | #10 | +29.37% | +0.84% | |
| 3 months | #98 | +8.95% | +3.59% | |
| 6 months | #46 | +40.89% | +17.95% | |
| 1 year | #5 | +311.40% | +16.25% | |
| Overall | #6 | sum of the six window ranks, ranked again | ||
R500 ranks the stock's gain over each window against the S&P 500 components over the same window (#1 = best). Near-real-time during market hours.
Fundamentals Biotechnology
| Metric | Value | Rank in S&P 500 | Rank in industry |
|---|---|---|---|
| Targeted Gain Median | #1 | #1 | |
| fPE/tPE | #1 | #1 | |
| PE/G | #1 | #1 | |
| EV/Revenue | 71.01 | #2 | #1 |
| Gross Margin | 0.99 | #7 | #1 |
| Profit Margin | 0.00 | #476 | #5 |
| Revenue Growth | 0.94 | #9 | #1 |